Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children


Kanra G., Marchisio P., Feiterna-Sperling C., Gaedicke G., Lazar H., Durrer P., ...Daha Fazla

PEDIATRIC INFECTIOUS DISEASE JOURNAL, cilt.23, sa.4, ss.300-306, 2004 (SCI-Expanded) identifier identifier identifier

Özet

Objective. To compare the immunogenicity and safety of a virosome-adjuvanted influenza vaccine (Inflexal V, Berna Biotech, Berne, Switzerland) and a split influenza vaccine (Fluarix; GlaxoSmithMine Biologicals, Rixensart, Belgium) in children.